Company foresees a ‘challenging’ 2009 business environment after reporting 19% revenue growth for 2008
Business Suite 7.0, emphasizes a modular, flexible approach to enterprise computing; according to Leo Apotheker, co-CEO of the Walldorf, Germany firm. “The days of big-bang implementations of enterprise applications are past.”
Business Suite 7.0 is the first time that SAP has been able to synchronize an upgrade across all of its applications, say Apothekar. The suite integrates analytics functions derived from its acquisition of Business Objects, and has a “harmonized” user interface to facilitate implementation and training. Another innovation SAP announced is industry-specific “value scenarios,” which are prepackaged combinations of SAP modules for distinct business applications, such as collaborative demand and supply planning.
“Business Suite 7.0 will give the life sciences industries more flexibility and more options in meeting their objectives in a highly regulated environment,” adds Andrew De, senior director, solution marketing for life sciences. “That flexibility extends to the differing situations of life science start-ups, mid-sized companies or large enterprises.”
De points out that the combination of the modular structure and SAP’s Netweaver architecture for data communications will enhance the ability to integrate SAP partner software products into the SAP environment. The company also announced that the systems integrators Atos Origin, Capgemini, IBM and Wipro will be the initial launch partners for Business Suite 7.0 implementations.
The week before the 7.0 announcement, SAP released its fiscal-year 2008 results, with non-GAAP revenue of $11.7 billion, up 19% over the previous year. The company had a great first half, but business slowed considerably in the second half—in Q4, software sales (which represent approximately 30% of the company’s total revenue) were down 6% as compared to Q42007. With the year-end announcement, SAP said it would undergo a first-ever staff cutback of an estimated 3,000 jobs over the next 12 months.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.